COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • January 14th, 2005 • Acadia Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE AGREEMENT (this “Agreement”) is entered into as of January 10, 2005 (the “Effective Date”) by and between ACADIA Pharmaceuticals Inc., a Delaware corporation (“ACADIA”), and Sepracor Inc., a Delaware corporation (“Sepracor”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • January 14th, 2005 • Acadia Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of January 10, 2005 (the “Effective Date”) by and between ACADIA Pharmaceuticals Inc., a Delaware corporation (“ACADIA”), and Sepracor Inc., a Delaware corporation (“Sepracor”).
LICENSE, OPTION AND COLLABORATION AGREEMENT by and between ACADIA PHARMACEUTICALS INC. and SEPRACOR INC. This document is the confidential information of both parties hereto. It should be distributed on a need-to-know basis and kept in a secure area.License, Option and Collaboration Agreement • January 14th, 2005 • Acadia Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS LICENSE, OPTION AND COLLABORATION AGREEMENT (“Agreement”) is by and between ACADIA PHARMACEUTICALS INC., a Delaware corporation (“ACADIA”), having an address of 3911 Sorrento Valley Boulevard, San Diego, CA 92121, and SEPRACOR INC., a Delaware corporation (“Sepracor”), having an address of 84 Waterford Drive, Marlborough, MA 01752.
